Breast cancer (BC) is a heterogeneous disease, encompassing a diverse spectrum of
tumours with varying morphological, biological, and clinical phenotypes. Although tumours …

Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and
molecular properties. Traditional classification use morphology to divide tumors into …

Background Recent data suggest that human epidermal growth factor receptor 2 (HER2)-
low breast cancer may represent a distinct entity. We aimed to compare disease …

Invasive lobular carcinoma of the breast is the most common 'special'morphological subtype
of breast cancer, comprising up to 15% of all cases. Tumours are generally of a good …

Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast
cancer after invasive ductal carcinoma (IDC), accounting for 10–15% of all breast cancer …

Purpose To evaluate the relative effectiveness of letrozole compared with tamoxifen for
patients with invasive ductal or lobular carcinoma. Patients and Methods Patients diagnosed …

Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast
cancer (BC): ILC differs from invasive ductal carcinoma (IDC) in its clinicopathological …

PURPOSE Nonadherence to long-term treatments is often under-recognized by physicians
and there is no gold standard for its assessment. In breast cancer, nonadherence to …

Approximately 70% of human breast tumors express hormone receptors (HRs), comprising
the estrogen receptor (ER) and/or progesterone receptor (PR). The ER is the primary …

Purpose: We queried whether comprehensive genomic profiling using a next-generation
sequencing–based assay could identify novel and unanticipated targets of therapy for …